Idiopathic pulmonary fibrosis in the UK: findings from the British Thoracic Society UK Idiopathic Pulmonary Fibrosis Registry
Fahim A. et al, (2025), BMJ Open Respiratory Research, 12, e002773 - e002773
Incidence of diabetes mellitus following hospitalisation for COVID‐19 in the United Kingdom: A prospective observational study
Tyrer F. et al, (2025), Diabetes, Obesity and Metabolism, 27, 767 - 776
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
Liew F. et al, (2024), Nature Immunology, 25, 607 - 621
Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID‐19
Devine K. et al, (2024), Clinical Endocrinology, 100, 317 - 327
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
Elneima O. et al, (2024), International Journal of Epidemiology, 53
Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis
Weeratunga P. et al, (2024), Journal of Clinical Investigation, 134
Long COVID research: an update from the PHOSP-COVID Scientific Summit
Brightling CE. et al, (2023), The Lancet Respiratory Medicine, 11, e93 - e94
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
Raman B. et al, (2023), The Lancet Respiratory Medicine, 11, 1003 - 1019
Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs.
Weeratunga P. et al, (2023), Nature communications, 14
Implementable Deep Learning for Multi‐sequence Proton MRI Lung Segmentation: A Multi‐center, Multi‐vendor, and Multi‐disease Study
Astley JR. et al, (2023), Journal of Magnetic Resonance Imaging, 58, 1030 - 1044
Neutrophil levels correlate with quantitative extent and progression of fibrosis in IPF: results of a single-centre cohort study.
Achaiah A. et al, (2023), BMJ open respiratory research, 10
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2
Wilkinson T. et al, (2023), ERJ Open Research, 9, 00249 - 2023
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.
Taquet M. et al, (2023), Nature medicine
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
Jackson C. et al, (2023), The Lancet Respiratory Medicine, 11, 673 - 684
Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis.
Dawson C. et al, (2023), BMJ open respiratory research, 10
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
Zheng B. et al, (2023), The Lancet Regional Health - Europe, 29, 100635 - 100635
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study
Stewart I. et al, (2023), American Journal of Respiratory and Critical Care Medicine, 207, 693 - 703
Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Absence in the Lungs of Fatal COVID-19: A Retrospective Histopathology Cohort Study
Melero I. et al, (2023), SSRN Electronic Journal
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study
McAuley HJC. et al, (2023), eClinicalMedicine, 57, 101896 - 101896